scholarly article | Q13442814 |
P50 | author | Charity G Moore | Q37371171 |
Kian Fan Chung | Q43222898 | ||
William W Busse | Q57330018 | ||
Eugene R Bleecker | Q65560413 | ||
Sally E Wenzel | Q88703108 | ||
Benjamin Gaston | Q97548008 | ||
Serpil C. Erzurum | Q99561107 | ||
W Gerald Teague | Q114398502 | ||
Elliot Israel | Q124853372 | ||
P2093 | author name string | Seo Young Park | |
Mario Castro | |||
Kenneth Wysocki | |||
P2860 | cites work | The Biomolecular Interaction Network Database and related tools 2005 update | Q24794410 |
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program | Q33725032 | ||
Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma | Q33868572 | ||
Nitric oxide and related enzymes in asthma: relation to severity, enzyme function and inflammation | Q36832237 | ||
Inflammatory biomarkers in severe asthma | Q37951831 | ||
Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients | Q43604746 | ||
Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma | Q44296679 | ||
Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics | Q44863693 | ||
"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids | Q44950357 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | asthma | Q35869 |
P304 | page(s) | 915-918 | |
P577 | publication date | 2013-12-09 | |
P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
P1476 | title | Characterization of factors associated with systemic corticosteroid use in severe asthma: data from the Severe Asthma Research Program | |
P478 | volume | 133 |
Q51723140 | Characterisation of an OCS-dependent severe asthma population treated with mepolizumab. |
Q37042266 | Current concepts of severe asthma |
Q38209438 | Defining phenotypes in asthma: a step towards personalized medicine |
Q38261186 | Emerging molecular phenotypes of asthma |
Q33735605 | Evolving Concepts of Asthma |
Q34960273 | Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways |
Q38463164 | Genome wide expression analysis of the effect of Socheongryong Tang in asthma model of mice |
Q38645834 | Neutrophilic Inflammation in Asthma and Association with Disease Severity |
Q39423956 | Severe Asthma Phenotypes - How Should They Guide Evaluation and Treatment? |
Q36471091 | Severe Asthma in Children: Lessons Learned and Future Directions. |
Q34304509 | So-Cheong-Ryong-Tang, a herbal medicine, modulates inflammatory cell infiltration and prevents airway remodeling via regulation of interleukin-17 and GM-CSF in allergic asthma in mice |
Search more.